Uncategorized
Positive long-term results reported for Leber’s hereditary optic neuropathy treatment
GenSight Biologics has reported that GS010, an intravitreal injection treatment for Leber’s hereditary optic neuropathy, has shown positive long-term visual acuity and safety results after 96 weeks, according to a company press release.In the phase 1/2 trial, a single intravitreal injection of GS010 was administered in the eye most severely affected by the disease.